- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07818057
Validity of the 3-item Patient Health Questionnaire (PHQ-3) for Identifying Moderate-to-Severe Depressive Symptoms Among Elderly Perioperative Patients: A Secondary Analysis of a National Prospective Cohort
September 9, 2026 updated by: Jingsheng Lou, Chinese PLA General Hospital
This is a retrospective observational study based on our hospital's prospective peri-operative elderly patient database.
We aim to evaluate the correlation between the 9-item Patient Health Questionnaire (PHQ-9) and the brief 3-item Patient Health Questionnaire (PHQ-3) for screening depressive symptoms among elderly surgical patients.
Secondary outcomes include the associations of the two scales with adverse events: 30-day post-operative mortality, readmission, surgical site infection, delirium, and 1-year all-cause mortality.
No additional interventions will be performed; only existing routinely-collected clinical data will be analysed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
10536
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, China, 100853
- Chinese PLA General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Elderly surgical patients aged 65 years or older who underwent non-neurosurgical and non-cardiac surgery under general anesthesia and were enrolled in our hospital's prospective perioperative database, with complete perioperative PHQ-3 and PHQ-9 assessments
Description
Inclusion Criteria:
- 1. Aged ≥ 65 years old 2. Patients undergoing surgery under general anesthesia
Exclusion Criteria:
- 1. ASA physical status ≥ IV (including ASA class IV) 2. Patients transferred to the intensive care unit (ICU) after surgery 3. Preoperative history of schizophrenia, epilepsy, or Parkinson's disease 4. Diseases requiring corticosteroid therapy for more than 7 days within 1 year before surgery 5. Preoperative inability to communicate (coma, severe dementia, or language/hearing impairment), or MMSE score < 26 6. Any cerebrovascular event within the past 3 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
1-year all-cause mortality after surgery
Time Frame: 12 months after surgery
|
12 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2020
Primary Completion (Actual)
April 30, 2022
Study Completion (Actual)
April 30, 2022
Study Registration Dates
First Submitted
September 9, 2026
First Submitted That Met QC Criteria
September 9, 2026
First Posted (Actual)
September 14, 2026
Study Record Updates
Last Update Posted (Actual)
September 14, 2026
Last Update Submitted That Met QC Criteria
September 9, 2026
Last Verified
September 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 301YXM02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.